| |
|
|
|
Synthetic Biologics Inc.  
|
|
2.44 -0.1 (-0.04%) |
09-25 16:00 |
|
Open: |
2.56 |
Pre close: |
2.54 |
Target:
|
3.20
|
|
High: |
2.65 |
Low: |
2.35 |
Resistance:
|
2.74
3.29
|
|
Volume: |
134,791 |
Market Cap: |
9M |
Support:
|
1.86
1.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.38
 |
MACD |
MACD(12,26):
|
-0.39 |
|
MA(20): |
2.55  |
Signal(12,26,9): |
-0.50 |
|
MA(100): |
6.10 |
Stochastic Oscillator |
%K(14,3):
|
56.85 |
|
MA(250): |
13.73 |
%D(3): |
48.91 |
|
Average Volume(K) |
3-Month: |
10283
|
52-Week |
High:
|
33.60 |
|
10-Days: |
20795 |
Low: |
1.86 |
|
RSI |
RSI(14):
|
38.01 |
Change(%): |
-92.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.950 |
Return on Equity (ttm) |
2800.7 |
Shares Out. (M) |
3.80 |
|
EPS Est. Current Year |
-0.170 |
Return on Assets (ttm) |
-176.8 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.50 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
134 |
|
Book Value (p.s.) |
21.960 |
EBITDA (p.s.) |
-1.523 |
P/E |
-0.41 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-18.84 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-17.78 |
P/CF |
-0.49 |
|
|
|
|
|
|
